September 2024

Exciting News in the Fight Against Cancer: Estrella Immunopharma Announces Positive Results in Clinical Trial EMERYVILLE, Calif.–(BUSINESS WIRE)–Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced that the first patient enrolled in its STARLIGHT-1…

Suffered Loss on Super Micro Computer, Inc. Investment? Learn About Potential Recovery Introduction If you are one of the investors who suffered a loss on your Super Micro Computer, Inc. (NASDAQ:SMCI) investment, you may be entitled to a potential recovery under the federal securities laws. It is essential to stay informed about your rights and…

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Starbucks To Contact Him Directly To Discuss Their Options New York, NY / ACCESSWIRE / September 27, 2024 Have you suffered losses exceeding $100,000 in Starbucks between November 2, 2023 and April 30, 2024? Are you looking…

Uncovering the Hidden Gems: A Quirky and Personal Look into the World of AccessWire Description: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Super Micro Computer To Contact Him Directly To Discuss Their Options. NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If…